השפעת הטיפול הפרטני מול קבוצתי בחולי סוכרת סוג 1 במרפאת סוכרת שלישונית

Slides:



Advertisements
Similar presentations
In the name of GOD In the name of GOD.
Advertisements

CCashman December 2006 GUT BUSTERS Anne Farrell, Workplace Health Promotion Officer, CIE Group.
Dudley Public Health & The Ridge Hill Centre Health Access Services Partnership By NHS Dudley Weight Management Team & Health Access Team May 2012.
Walter Lab: Gut microbiome and its interactions with metabolic disease
 A 12-month incentive based weight loss study aimed to reduce weight and improve overall health of Singaporeans.  Conducted by Duke-NUS Graduate Medical.
10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
Dr. Chris Cobourn Medical Director and Surgeon Surgical Weight Loss Centre Staff Surgeon Trillium Health Centre Mississauga, Ontario.
“Effects of the Croí CLANN structured lifestyle modification programme on anthropometric and metabolic characteristics in severely obese adults” Irene.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Diabetes and The Family: Strategies for Successful Management and Clinical Outcomes.
Chronic Disease Risk Factors: 6th Grade Student Health Screenings Deanna Hanson, MSN RN, BC Beth Whitfield, BSN, RN, MAE Western Kentucky University Fall.
Exercise and Mental Health Counseling Services Exercise and Mental Health Counseling Services Resources and Expectations for Affiliated Programs.
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
Quality of life improves after patients switch to biphasic insulin aspart 30/70 (BIAsp 30): IMPROVE™ Study data from 39,015 patients M. Benroumpi 1, T.
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
1 Adding Value to Healthcare Management: Patient Self-Management: Diabetes MICHPHA September 20, 2007 Brooke Bliss, R.Ph. Clinical Pharmacy Consultant.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
24 May How I Introduce Insulin in Type 2 Diabetes Mellitus Sheena Duffus Diabetes Specialist Nurse Norma Alexander Sister Diabetes Clinic.
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
Diabetes update Gillian Clarke Diabetes Lead/Advanced Dietitian.
Health Disparities/ Diabetes Care Sheldon Greenfield, MD Orange County Diabetes Education Collaborative Conference January 31, 2009.
A Diabetes Outcome Progression Trial
Lesotho STEPS Survey 2012 Fact Sheet John Nkonyana Director Disease Control.
1 Challenges and Opportunities In Managing Diabetes and Hyperglycemia Module 2 Diabetes Special Interest Group Georgia Hospital Association.
Do Group Visits Improve Care? Results of a Diabetes Group Visit Model in a Family Medicine Residency Authors: Josephine Agbowo MD, Grace Chen Yu, MD Location:
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
Gerti Tashko, M.D. DM Journal Club 12/16/2010. The use of exenatide with insulin is not FDA approved. The study was designed to evaluate if exenatide.
Zainudin S 1, Ang DY 2, Goh SY 1, Soh AW 1. Department of Endocrinology, Singapore General Hospital, Singapore 1 ; Yong Loo Lin, School of Medicine, National.
Chronic Disease Management Mitigates the Relationship between Literacy and Health Outcomes Darren A. DeWalt, MD, MPH RWJ Clinical Scholars Program Division.
Cost-Effectiveness of Treatment Strategies for Comorbid Diabetes and Dyslipidemia Part 2.
Health Care, Education and Research Date: Oct 11, 2016 An Overview of the Efficacy of Delivering DSME and Group- Based DSME via Telehealth Barb Holloway,
Metabolic Comorbidities of Young Children
Multicenter, Placebo-Controlled Trial
Noncommunicable Diseases Surveillance in Egypt
Prevention Diabetes.
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
Sofija Zagarins1, PhD, Garry Welch1, PhD, Jane Garb2, MS
Assessment of dietary compliance among patients with type ii diabetes mellitus receiving text message (sms) reminder: a randomized control trial Gulshan.
*Philippa Boulle1, Gustavo Fernandez1, Maria Lightowler2
Maintaining a Healthful Weight
Seema Jain1, Rebecca Andridge2, Jessica Hellings3
Dietary patterns in a group of medical students
Comparison between the Effect of Six Weeks Morning or Evening Aerobic Exercise on Appetite and Anthropometric Indices Zahra Alizadeh, MD Assistant Professor.
Diabetes and Obesity Journal Club Carina Signori, D.O., M.P.H.
Vanguard Phase Results for the Blood Pressure Component
Jessica Lobban, PGY-3 CCLP Family Medicine Residency Program
Prevalence Of Metabolic Syndrome And Assessment Of Nutritional And Biochemical Parameters Of Overweight And Obese Working Women 1Upasana, 2Chakravarty.
Neal B, et al. Diabetes Care 2015;38:403–411
Peer-led Diabetes Prevention Program for TASC in Melbourne
by Sarah Steinmetz and Amber Brouillette
Supplementary material
Jonathan W. Decker, MSN, ARNP, PhD-c Karen E. Dennis, PhD, RN, FAAN
Osborne K.B., Davies S.J., Coppini D.V.
Essential Amino Acids and Phytosterols promote Improvements in Metabolic Risk Factors in Overweight Individuals with Mild Hyperlipidemia RH Coker1,2,
Diabetes Health Status Report
Management of Type II Diabetes
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
DiRECT (Diabetes Remission Clinical Trial)
GLP-1 Receptor Agonists: A Tool for the Primary Care Physician to Reduce CV Risk in Diabetes?
Diabetes Prevention Programme
Fort Atkinson School District Wellness Program
Section overview: Cardiometabolic risk reduction
Chapter 26 Endocrine Function
Hertfordshire Community Diabetes Service Diabetes Dietitians
The complications of obesity according to the values of BMI and waist circumference in an obese population of Tangier Nadia HAMJANE 1, Fatiha BENYAHYA1,2,
Obesity Eppie Habashi.
An Association Between Provider Stigma and Metabolically Healthy
User Personas Templates
Nutrition Interventions to Improve Quality of Care
Presentation transcript:

השפעת הטיפול הפרטני מול קבוצתי בחולי סוכרת סוג 1 במרפאת סוכרת שלישונית ד"ר ג'ואל זינגר מרכז רפואי רבין, ב"ח בילינסון מכון אנדוקריני

Death

Diabetes medication

HbA1c

Hba1c at 12-14 months

Hba1c at 2 years

Weight

Weight 12-14 months

Diabetes knowledge

Systolic Blood Pressure

Triglycerides

Ester Boteach RN,MPH, Shula Witkow RD,MPH and Ilana Harman-Boehm MD The Effect of Interventional Group Therapy on Glucose Control and Weight Loss in Obese "Non-compliant“ Patients with Type 2 Diabetes Mellitus Ester Boteach RN,MPH, Shula Witkow RD,MPH and Ilana Harman-Boehm MD Introduction Group interventions have been shown, overall, to be effective in the management of people with diabetes. Their efficacy in the sub-group of patients considered "non-compliant" remains to be demonstrated. Type 2 diabetic patients defined as "non-compliant" are often characterized by overweight, high doses of hypoglycemic agents and/or insulin, poor glucose control and insufficient knowledge of their disease despite repeated individual instruction by the clinic staff. Objective: To study the effects of interventional group-therapy delivered by a nurse-dietician diabetes educator team on blood glucose and weight control in a group of non-compliant type 2 diabetes patients. Methods: 20 uncontrolled overweight diabetic patients, members of the local Israel Diabetes Association chapter in Beer-Sheva and 8 spouses, were enrolled in a group therapy program run by a nurse and a dietician, both diabetes educators. At enrollment all participants signed a written agreement to attend most meetings, uphold the rules of the group and pay a symbolic fee. 10 weekly sessions took place, each lasting 2 hours. Each interactive session included weight, waist and hip measurements. The topics covered included general knowledge of diabetes, practicing self-management, hypoglycemic agents, diet therapy including snacking and eating during holidays, physical activity under different circumstances, emphasizing activities for partially disabled patients, fighting negative thoughts, personal assessment of glycemic control and overcoming obstacles to better control. Blood samples were taken at meeting 1 and 10 for HbA1C. In order to better mirror the effects of their own habits, each participant kept a daily diary of food and physical activity and graded his weekly progress in each of three treatment modalities: diet, activity and medication adherence on a scale of 1-low to 5-high. Each session ended with a smile elicited by a weekly cartoon on the topic discussed. At the last meeting the attendants were asked to state which habits would be permanently adopted and which not. Table 1: Patient Data at Baseline Figure 1: Changes in Weight (Kg) at the End of Intervention Period Figure 3 :Changes in HbA1C at the end of intervention period Figure 4: Changes in Waist Circumference at the end of intervention period Figure 5: Changes in Hip Circumference at the End of Intervention Period Figure 6: Example of our way to get a smile at the end of each meeting. I wished I had her Metabolism Summary: 15 diabetes patients attended most meetings. They were heterogeneous in terms of age, gender, duration of disease, hypoglycemic agents and motivation for in HbA1C, weight, BMI, waist circumference, hip circumference, were 0.96 ± 0.9%, 3.2 ±2.4 Kg. 1.14±0.8, 4.3±4.3 cm and 4.4±4.9 cm respectively. The doses of oral hypoglycemic agents as well as daily insulin were lowered. Conclusions: Interventional group therapy performed by experienced diabetes educators, resulted in marked improvement of glycemic and weight control. The power of the group appeared to be a strong determinant of the behavior of the individual.

Protocol Patients with type 1 or type 2 diabetes mellitus attending Diabetes Clinic Randomized to group visits or personal visits by the same physician for 1 year

Outcomes Composite outcome: HbA1c, Weight, Blood pressure differences at 1 year Secondary outcome: PAID, WHO QoL, Concerns about diabetes questionnaires scores differences at 1 year General Practitioner visits number at 1 year

65 patients agreed to participate and signed informed consent ( T2DM N=38, T1DM N=27) Group visits were scheduled once every 4 months Personal visits according to availability and needs T2DM patients and T1DM patients were scheduled in different group visits

Every group visit was 1.5 hours long 30 mn were the physician did a file and lab review while the nurses took anthropometric measures and short education tools when needed 45 mn group visits with patients & physician: free discussion 15 mn with short personal visit to give the consultation letter for the GP

Table 2B. Comparison between control and study group in Diabetes Type 1. P value n Mean SD N . WHO 11 17.1 28.4 16 4.25 23.1 .21 Paid 8 -.2 .2 15 .1 .4 .03 PMDC severe .6 .71 PMDCCont diff ,2 ,1 1.0 .89 PMDC inf .8 .93 PMDCeffDiff .06 .60 .80 .31 Weight 7 -2.4 4.2 14 1.2 .15 BMI -.8 1.4 -.1 HbA1C -.4 .7 .14 SBP 5.5 15.2 9.2 15.4 .59 DBP 1.5 9.7 5.2 8.4 .36 NonHDL -8.3 17 12 20.6 .29 LDL GPDiff 9 -5.2 10 -1.2 8.1 .22 Average Diff -3.6 6.0 8.5 .51 Admit Diff .45 .32 GP year 17.3 7.1 14.1 4.7 .19 Avevisityear admityear -.42 .70 1.3 .49

Conclusions Group therapy seems to be as safe as personalized therapy in patients with diabetes type 1

Clinical inertia & Personal Conclusion The physician part: don’t confuse me with facts Changing treatment paradigm in chronic disease to improve the life of people with diabetes is a very slow process